Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cellchem Femcare Probiotics is an oral live bacterial supplement distributed by Cellchem Pharmaceuticals, a Canadian supplier of generic and branded pharmaceuticals. Marketed as an over-the-counter (OTC) consumer product, it is specifically formulated to support female health by maintaining a balanced microbiome in the vaginal and urinary tracts. As a probiotic, it functions by introducing beneficial bacterial strains that help restore natural flora, compete with pathogenic microorganisms for resources and adhesion sites, and produce metabolites such as lactic acid to maintain an optimal pH environment. This microbial balance supports the body's natural defenses against common infections such as bacterial vaginosis and urinary tract infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cellchem Femcare Probiotics.